📰 Dror Bashan News
Dror Bashan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dror Bashan. Real-time updates on events, politics, business and more.
December 4, 2023
StockNews.com upgraded shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday. PLX has been the topic of several other reports. TheStreet raised shares of Protalix BioTherapeutics from a d- rating to a c- rating in a report on Monday, […]
December 4, 2023
StockNews.com upgraded shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) from a hold rating to a buy rating in a report published on Thursday. Several other research firms also recently commented on PLX. HC Wainwright reaffirmed a buy rating and set a $10.00 price objective on shares of Protalix BioTherapeutics in a research note on […]
December 1, 2023
Protalix BioTherapeutics (NYSE:PLX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Thursday. Several other analysts also recently commented on the stock. TheStreet upgraded shares of Protalix BioTherapeutics from a “d-” rating to a “c-” rating in a […]
November 16, 2023
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Stock analysts at HC Wainwright boosted their FY2023 EPS estimates for shares of Protalix BioTherapeutics in a note issued to investors on Tuesday, November 14th. HC Wainwright analyst R. Selvaraju now expects that the company will earn $0.16 per share for the year, up from their prior […]
November 7, 2023
Operator: Good morning, ladies and gentlemen. And welcome to the Protalix Biotherapeutics Third Quarter 2023 Financial and Business Results Conference Call.
October 23, 2023
The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
October 9, 2023
By Chris Wack Protalix BioTherapeutics said Monday that its operations in Israel haven't been affected by the recent violence. The biopharmaceutical company...
September 12, 2023
/PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...
August 8, 2023
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Good morning, ladies and gentlemen and welcome to the Protalix BioTherapeutics Conference for Second Quarter 2023 Financial Business Results. As a reminder, this conference is being recorded. I will now turn the conference over to our host, Mr. Chuck Padala with LifeSci […]
August 7, 2023
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization...